https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-01 / Immunity 2007 Sep;27(3):481-92
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-01 / Immunity 2007 Sep;27(3):481-922007-09-01 00:00:002019-02-15 09:15:08Antigen crosspresentation by human plasmacytoid dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-01 / J. Immunol. 2007 Sep;179(5):2860-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-01 / J. Immunol. 2007 Sep;179(5):2860-92007-09-01 00:00:002019-02-15 09:16:56Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-01 / Oncol. Rep. 2007 Sep;18(3):665-71
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-01 / Oncol. Rep. 2007 Sep;18(3):665-712007-09-01 00:00:002019-02-15 09:16:57Combined treatment of dendritoma vaccine and low-dose interleukin-2 in stage IV renal cell carcinoma patients induced clinical response: A pilot study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-28 / Ann. Nutr. Metab. 2007;51(4):301-23
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-28 / Ann. Nutr. Metab. 2007;51(4):301-232007-08-28 00:00:002007-08-28 00:00:00Contribution of selected vitamins and trace elements to immune function
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-23 / Tumour Biol. 2007;28(4):238-46
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-23 / Tumour Biol. 2007;28(4):238-462007-08-23 00:00:002007-08-23 00:00:00Dendritic cells reconstituted with a human heparanase gene induce potent cytotoxic T-cell responses against gastric tumor cells in vitro
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-20 / AIDS 2007 Aug;21(13):1683-92
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-20 / AIDS 2007 Aug;21(13):1683-922007-08-20 00:00:002007-08-20 00:00:00Levels of antigen processing machinery components in dendritic cells generated for vaccination of HIV-1+ subjects
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-15 / Cancer Res. 2007 Aug;67(16):7798-806
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-15 / Cancer Res. 2007 Aug;67(16):7798-8062007-08-15 00:00:002019-02-15 08:48:34Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-01 / Int. J. Cancer 2007 Aug;121(3):467-73
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-01 / Int. J. Cancer 2007 Aug;121(3):467-732007-08-01 00:00:002019-02-15 09:24:08Immunotherapy with dendritic cells for prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):431-42
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):431-422007-08-01 00:00:002007-08-01 00:00:00Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):417-29
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):417-292007-08-01 00:00:002007-08-01 00:00:00Benefits of superficial hyperthermia treatment planning: five case studies
